Key highlights Ozempic (semaglutide) is FDA-approved for type 2 diabetes management and Zepbound (tirzepatide) is approved for chronic weight management in obese and overweight individuals
There have also been reports of stomach paralysis, a condition known as gastroparesis (delayed stomach emptying), potentially related to Ozempic, though these claims have yet to be substantiated
Protocols and their amendments are publicly accessible in ClinicalTrials.gov under the National Clinical Trial (NCT) identifiers NCT06659744, NCT07088718 and NCT07096063, and in the Open Science Framework (osf.io/38rw9) 43
MOQ is confirmed based on strength, presentation, and requested brand/manufacturer
While some people try to buy compounded tirzepatide online and compounded semaglutide to save money, its risky because the dosing might not be accurate, and the medication might not be made under proper safety standards